PRESS RELEASE

Cambridge, Mass. June 15, 2013

Manus Bio is awarded a Phase I STTR Grant from the National Science Foundation for the development of a novel pathway for terpenoid biosynthesis

Manus Bio, a leader in metabolic engineering and synthetic biology, announced today that it has been awarded a prestigious National Science Foundation grant under the Small Business Technology Transfer (STTR) program. This Phase I award ($225,000) supports the design and engineering of a de novo pathway for terpenoid production. The full abstract for the project entitled “Overcoming Metabolic Pathway Limitations through De Novo Pathway Design for Terpenoid Biosynthesis” can be found at https://www.sbir.gov/sbirsearch/detail/683834.

Manus Bio leverages rapid advances in Biology to produce complex natural ingredients used in our daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. Using its advanced fermentation technology, Manus Bio recreates natural processes for next-generation industrial biomanufacturing and provides sustainable and cost-effective sources of ingredients for health, wellness, and nutrition. To learn more, visit www.manusbio.com.